Tatsuya Toyama

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Venues

Cancer science

Breast cancer research and treatment

Breast cancer (Tokyo, Japan)

JMIR formative research

This page only lists publications with an associated author ORCID identifier.

Publications

Nari Kureyama, Mitsuo Terada, Maho Kusudo, Kazuki Nozawa, Yumi Wanifuchi-Endo, Takashi Fujita, Tomoko Asano, Akiko Kato, Makiko Mori, Nanae Horisawa, Tatsuya Toyama
Fact-Checking Cancer Information on Social Media in Japan: Retrospective Study Using Twitter. JMIR formative research 7 (2023)
Yutaka Yamamoto, Hiroji Iwata, Naruto Taira, Norikazu Masuda, Masato Takahashi, Tetsuhiro Yoshinami, Takayuki Ueno, Tatsuya Toyama, Takashi Yamanaka, Toshimi Takano, Masahiro Kashiwaba, Koichiro Tsugawa, Yoshie Hasegawa, Kenji Tamura, Hiroshi Tada, Fumikata Hara, Tomomi Fujisawa, Naoki Niikura, Shigehira Saji, Satoshi Morita, Masakazu Toi, Shinji Ohno
Pertuzumab retreatment for HER2-positive advanced breast cancer: A randomized, open-label phase III study (PRECIOUS). Cancer science 113 (9) (2022)
Kiyoshi Minohara, Masaki Imai, Takuma Matoba, James Badger Wing, Hiroaki Shime, Mizuyu Odanaka, Ryuta Uraki, Daisuke Kawakita, Tatsuya Toyama, Satoru Takahashi, Akimichi Morita, Shingo Murakami, Naganari Ohkura, Shimon Sakaguchi, Shinichi Iwasaki, Sayuri Yamazaki
Mature dendritic cells enriched in regulatory molecules may control regulatory T cells and the prognosis of head and neck cancer. Cancer science (2022)
Kiyoshi Minohara, Masaki Imai, Takuma Matoba, James Badger Wing, Hiroaki Shime, Mizuyu Odanaka, Ryuta Uraki, Daisuke Kawakita, Tatsuya Toyama, Satoru Takahashi, Akimichi Morita, Shingo Murakami, Naganari Ohkura, Shimon Sakaguchi, Shinichi Iwasaki, Sayuri Yamazaki
Mature dendritic cells enriched in regulatory molecules may control regulatory T cells and the prognosis of head and neck cancer. Cancer science (2022)
Mitsuo Terada, Naoto Kondo, Yumi Wanifuchi-Endo, Takashi Fujita, Tomoko Asano, Tomoka Hisada, Yasuaki Uemoto, null Akiko Kato, Natsumi Yamanaka, Hiroshi Sugiura, Keiko Mita, Asaka Wada, Eriko Takahashi, Kanako Saito, Ryo Yoshioka, Tatsuya Toyama
Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: a multi-center prospective observational study. Breast cancer research and treatment 195 (3) (2022)
Sayaka Nishikawa, Yasuaki Uemoto, Tae-Sun Kim, Tomoka Hisada, Naoto Kondo, Yumi Wanifuchi-Endo, Takashi Fujita, Tomoko Asano, Yusuke Katagiri, Mitsuo Terada, Akiko Kato, Yu Dong, Hiroshi Sugiura, Katsuhiro Okuda, Hiroyuki Kato, Satoshi Osaga, Satoru Takahashi, Tatsuya Toyama
Low RAI2 expression is a marker of poor prognosis in breast cancer. Breast cancer research and treatment 187 (1) (2021)
Tatsuya Toyama, Akiyo Yoshimura, Takako Hayashi, Naomi Kobayashi, Kanako Saito, Michiko Tsuneizumi, Masataka Sawaki, Masaya Hattori, Takumi Nakada, Isao Yokota, Hiroji Iwata
A randomized phase II study evaluating pyridoxine for the prevention of hand-foot syndrome associated with capecitabine therapy for advanced or metastatic breast cancer. Breast cancer (Tokyo, Japan) 25 (6) (2018)

Tatsuya Toyama.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tatsuya Toyama